But, most importantly, the CF condition alters cAMP-mediated signaling and phosphorylation of CBP in response to CFTR loss [51], thereby reducing Nrf2 association, activity and expression [52,53]. The gene discussed is NFE2L2; the disease is cystic fibrosis.